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ABSTRACT

REGULATION OF POTASSIUM TRANSPORT IN RAT MESANGIAL
CELLS: A FLUORESCENT ANALYSIS USING THE POTASSIUMSENSITIVE DYE, PBFI. Scott E. Kasner and Michael B. Ganz. Section
of Nephrology, Department of Medicine, and Department of Cellular and
Molecular Physiology, Yale University School of Medicine, New Haven,
CT. 1992.

We investigated the regulatory transport processes that maintain
potassium homeostasis in cultured rat glomerular mesangial cells
(MCs). Intracellular potassium concentration ([K+]i) of MCs was
measured by spectrofluorometry using the potassium-sensitive dye,
potassium-binding benzofuran isophthalate (PBFI). Ionophores
valinomycin and nigericin were used to clamp [K+]j to known [K+]0 and
thereby obtain an intracellular calibration of the dye. Normal resting
[K+]i in MCs was 102 ± 7 mM. When MCs were exposed to ouabain,
[K+]i fell to 48 ± 6 mM and did not recover, suggesting the presence of
the the Na+/K+-ATPase. When MCs were exposed to furosemide, [K+]i
transiently declined to 58 ± 11 mM that was followed by rapid recovery to
near steady-state, indicating the additional presence of the Na+/K+/Cl‘
cotransporter. Recovery was completely abolished when MCs were
exposed to ouabain. Exposure to barium led to an immediate increase in
[K+]j to 124 ± 8 mM followed by a rapid return to steady-state [K+]i.
Resting [K+]i was not altered by angiotensin II (ANG II), serotonin (5HT), bradykinin (BK), or atrial natriuretic peptide (ANP). ANG II, 5HT, and BK stimulated the Na+/K+-ATPase by 28, 41, and 24%,
respectively, as measured during recovery of [K+]i toward normal
following a diuretic-induced fall in [K+]i. ANG II and 5-HT also
significantly stimulated the activity of the Na+/K+/Cl‘ cotransporter, by
55 and 47%, respectively. BK had no significant effect on the
cotransporter, and ANP had no significant effect on either the ATPase

or the cotransporter. We conclude: 1) MCs possess the ouabainsensitive Na+/K+-ATPase, the loop diuretic-sensitive Na+/K+/Cl‘
cotransporter, and barium-sensitive K+ channels. 2) ANG II, 5-HT,
and BK stimulate the Na+/K+-ATPase, but only ANG II and 5-HT
stimulate the Na+/K+/Cl' cotransporter in MCs. ANP had no
significant influence on either. 3) Continuous measurement of [K+Ji
and an examination of its regulatory mechanisms in MCs can be
achieved through the use of the fluorescent dye, PBFI.
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INTRODUCTION

Overview

Vasoactive agents have been shown to regulate glomerular filtra¬
tion, presumably by eliciting changes in glomerular surface area via
mesangial cell contraction and relaxation. Moreover, many of these
agents have been demonstrated to influence ion transport mechanisms
in contractile cells. Potassium transport mechanisms have been pro¬
posed to play a key part in mesangial cell volume and shape regulation,
and they may be modulated by vasoactive agents. The mechanisms of
potassium transport and their roles in determination of membrane
potential and regulation of cell volume will be briefly discussed in the
following sections. The effects of vasoactive agents on these cellular
functions will also be reviewed. We sought to evaluate the effects of
vasoactive agents on mesangial cell potassium transport during
hormonally-induced alterations in mesangial cell shape. This was
accomplished through the use of the novel potassium-sensitive
fluorescent dye, PBFI.

Mesangial Cells and Glomerular Filtration

The mammalian renal glomerulus is a microvascular network
which serves as the site of ultrafiltration of plasma. This capillary
network is comprised of epithelial, endothelial, and mesangial cells, as
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well as an unique basement membrane. The process of ultrafiltration
appears to be dependent on the interactions among these three cell types,
in addition to regulatory systemic and local factors. Recent evidence has
emerged indicating that the glomerulus is both a target for, and a site of
synthesis of, endogenous vasoactive agents. These hormones are
thought to play an important role in the regulation of the glomerular
filtration rate (GFR).

The filtration rate for a single glomerulus (single nephron glomeru¬
lar filtration rate, SNGFR) is determined by the relationship between the
hydraulic pressure (P) and oncotic pressure (11) gradients across the
glomerulus, as well as the ultrafiltration coefficient (Kf):

SNGFR = Kf (AP - AU)

Kf is a composite parameter which is defined as the product of the
effective hydraulic permeability of the capillary wall and the capillary
surface area available for filtration (15). Consequently, SNGFR can be
changed by a perturbation in any one or more of these factors.
Hydraulic and oncotic pressure alterations may occur at systemic,
whole kidney, or local levels and will not be discussed here. The effective
hydraulic permeability appears to maintain a relatively constant value
in mammals, and it has been suggested that differences in Kf between
and within species are predominantly a function of variations in
capillary surface area (16,65).
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A wide variety of humoral agents have been shown to regulate Kf:
angiotensin II (ANG II), arginine vasopressin (AVP), parathyroid
hormone (PTH), norepinephrine, acetylcholine (ACh), bradykinin (BK),
histamine (HIS), and prostaglandins (PG) E2 and I2 (4,32,67). Although
the glomerular response to ANG II is most extensively studied, it has
been observed that the changes in glomerular filtration caused by PTH,
HIS, PGI2, PGE2, and dibutyryl cyclic AMP (DBcAMP) are strikingly
similar to those caused by ANG II (67). However, the decline in Kf
caused by all of the aforementioned agents can be completely blocked by
the specific ANG II antagonist, saralasin (67). This implies that these
hormones exert their effect on the glomerulus by an ANG II-dependent
pathway. It has thus been suggested that these vasoactive agents act in
part by stimulating local synthesis and release of ANG II. Further
work confirmed this hypothesis; the juxtaglomerular epithelial cells
contain all of the enzymes required for the synthesis of ANG II, in
addition to those used in the synthesis of renin (9). Therefore, within the
glomerulus itself lies the machinery to regulate filtration.

Renal glomerular mesangial cells (MCs) are smooth muscle-like
cells that occupy the highly specialized interstitium of the glomerulus.
Their interposition between endothelial and epithelial cells, combined
with their abundant intracellular contractile myofilaments, make them
particularly well-suited for a key role in the modulation of GFR via their
ability to alter their shape and surface area (66). MCs also appear to
have an immunological function, and proliferation of these cells has
been implicated in the inflammatory response to glomerular injury
(35,76).
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MCs in culture have been demonstrated to have binding sites for the
vasoactive peptide, ANG II, and will contract in response to this agent
(3). In addition, cultured MCs exhibit contractile responses to other
vasoactive substances, such as AVP and norepinephrine, as well as to
mediators of inflammation including HIS and serotonin (3,16,38,39,46).
Atrial natriuretic peptide (ANP) appears to inhibit the contractile
response (2). To date, only ANG II, AVP, and norepinephrine have been
demonstrated to stimulate specific receptors on MCs leading to con¬
traction (3,46). The ANG Independent agents described above have no
contractile effect on isolated cultures of MCs (3,39), thus providing
further support for ANG II as a mediator in the regulation of Kf and
SNGFR.

Many stimuli for contraction are also known to influence specific ion
transport systems in contractile cells (6,8,19,31,53,62,78). Ion transport
is of major importance in the regulation of volume in all eukaryotic
cells, and is likely to be of particular significance in cells that are
frequently changing their shape and surface area. Vascular tone is
clearly dependent on membrane potential, which in turn is a function of
the transmembrane ion gradients and conductivity. In vascular smooth
muscle, regulation of potassium (K+) transport mechanisms is thought
to play a critical role in the control of vascular tone at the cellular level
(13,26,51). Vasoactive agents have been recently found to regulate K+
flux pathways in vascular smooth muscle cells, and evidence is emerg¬
ing that these pathways are also closely regulated in MCs. Thus,
identification of the mechanisms of K+ homeostasis in MCs and investi-
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gation of the behavior of the K+ transporters during hormonally-induced
MC contraction and relaxation is crucial for understanding the role of
the MC in glomerular filtration.

Mechanisms of Cell Potassium Homeostasis

The maintenance of a high intracellular potassium concentration is
essential for many processes including cell growth, enzyme activity, cell
volume regulation, and determination of membrane potential. Cell
potassium concentration is determined by the balance of influx and
efflux across the cell membrane, including processes of active and
passive transport. The cell membrane may be conceived as a barrier to
ionic species. Spanning this lipid bilayer are integral membrane
proteins that transport non-lipid-soluble substances through the barrier

(61).

Three categories of membrane transport proteins are described. The
first major type of transport mechanism works passively, moving ions
down their electrochemical gradients without dependence on other ions.
Passive transport commonly occurs through ion-specific channels.
Primary active transport mechanisms utilize the chemical energy from
ATP hydrolysis in order to move ions across a membrane. In general,
ions are moved against either a concentration gradient or an electrical
gradient by this system. Secondary active transport, or coupled trans¬
port, does not require the chemical energy of hydrolysis. Instead, it
makes use of the potential energy of the electrical or concentration

gradient of one ion to drive another ion against its own gradient. This
can occur with the solutes being simultaneously transported in the
same direction or opposite directions. Such mechanisms are known as
cotransporters and exchangers (or antiporters), respectively.

Membrane transport of potassium is generally performed by one or
more of four major pathways. The sodium/potassium ATPase (Na+/K+ATPase) pumps sodium (Na+) out of the cell and K+ into the cell,
hydrolyzing ATP in order to transport both ions against their concen¬
tration gradients. The inward Na+ gradient can drive simultaneous
transport of Na+, K+, and two chloride (Cl") ions into the cell via a
secondary active transporter, the Na+/K+/Cl' cotransporter (also known
as the Na+/K+/2C1' cotransporter). K+ efflux may occur via K+
channels or a K+/C1" cotransporter. The function of each cell type will
determine which of these K+ transporters will be present, as well as the
number of transport molecules, and the appropriate mechanisms for
regulation. In most cases, intracellular K+ concentration ([K+]i) is
maintained at a steady-state value under normal conditions by a
dynamic equilibrium among the multiple K+ transporters (61). In
contractile cells, at least three of the major K+ transport mechanisms
have been demonstrated to be involved in K+ homeostasis: the Na+/K+ATPase, the Na+/K+/Cl' cotransporter, and K+ channels (17,62). The
coordinated interaction of these mechanisms thus keeps [K+]i relatively
constant at a level well above the extracellular K+ concentration ([K+]0).
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Potassium and Membrane Potential

Potassium is an important factor in the determination of membrane
potential. The large K+ gradient across the membrane is maintained by
the balanced interactions of the many ion transporters. Further, resting
cell membranes are generally more permeable to K+ than to Na+, Cl", or
other ions. Membrane potential depends on both the magnitude of the
gradient and the permeability for each ion, and therefore is determined
predominantly by K+. The equilibrium potential for a particular ion is
defined as the potential at which there is no net ion transfer across the
membrane, i.e., when the forces on the ion are equal on both sides of the
membrane. In the case of K+, the chemical potential of the concen¬
tration gradient drives K+ outward because [K+]i is greater than [K+]0,
and the electrical potential pulls K+ inward since the cell is electro¬
negative inside and attracts positively-charged ions. No net potassium
current flows when these forces are balanced, and K+ is at equilibrium
across the membrane. This equilibrium potential for K+ (Ek) is also
known as the Nemst potential and is calculated as:

RT
[K+]0
Ek = — InzF
[K+]i

where R is the gas constant, T is the absolute temperature, z is the
charge of the ion, and F is the Faraday constant. For example, a
hypothetical cell with a K+ concentration of 140 mM inside and 4 mM
outside would have an Ek of approximately -90 mV. In a living cell, the
measured membrane potential (Em) is usually near Ek, and is
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generated not only by K+, but by other ions to which the membrane may
also be permeable (11).

In arterial smooth muscle cells, Em ranges between -35 mV and -75
mV (26,51). These cells have a relatively lower permeability to K+ than
other excitable tissues and a somewhat higher ratio of Na+ to K+
permeability (26). Moreover, vascular smooth muscle can alter its K+
conductance in response to environmental changes (29). Small changes
in [K+lo therefore do not lead to dramatic alterations of Em. Nonethe¬
less, small graded potential changes in Em do lead to significant
changes in intracellular calcium concentration, which is the major
regulator of the smooth muscle contractile apparatus. Thus, slight
depolarization may cause a marked increase in tone and slight hyper¬
polarization can lead to relaxation (8,33,70). It is also well documented
that depolarization of smooth muscle will lead to a significant increase
in tension induced by norepinephrine, whereas hyperpolarization
results in a diminished contractile response to several vasoactive
agents, particularly norepinephrine (8,25,27). The actual relationship
between the effect of vasoactive agents and Em is unclear, however. In
many studies, norepinephrine-induced contraction of smooth muscle
was found to occur in the absence of membrane depolarization; this
phenomenon is referred to as pharmacomechanical coupling (75). It
appears that the value of Em is an important factor in the development
of tension in contractile tissue, but the initiating event, either electro- or
pharmacomechanical, seems to depend on the specific cell type (26).
Further, the influence of vasoactive agents on K+ conductance and other
K+ transport mechanisms is likely to be a critical factor in the regula-

9

tion of membrane potential and vascular tone. This accentuates the
biological importance of understanding K+ homeostasis in cells. These
issues have not been explored with regard to mesangial cell
contractility.

Potassium and Cell Volume Regulation

Potassium is the predominant intracellular cation in most
eukaryotic cells, and as such, its transport is of major importance in the
control of volume in both isotonic and anisotonic media. In the steady
state, ion transporters maintain transmembrane ion gradients while
water flows freely across membranes to balance intra- and extracellular
osmolality. This state can be disrupted by cellular injury such as
hypoxia, or by substances which interfere with specific transport
mechanisms.

An osmotic "crisis" can be created by inhibition of the Na+/K+ATPase with ouabain. As soon as the ATPase is inactivated, the cell
loses its ability to balance K+ efflux (i.e., via channels) with an equal
influx, and also cannot oppose the inward Na+ gradient. Na+ flows
inward as K+ exits in order to maintain electroneutrality. The loss of
intracellular K+ reduces the equilibrium potential for K+ and the cell
depolarizes. Depolarization then allows small anions, predominantly
Cl", to move into the cell along their electrochemical gradients. The
relative number of anionic molecules in the cell (including both the
polyvalent macromolecules and Cl") increases, and thus a greater
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amount of Na+ is drawn inward. The net result of ATPase inhibition is
thus an accumulation of osmotically active particles within the cell.
Water moves into the cell to equilibrate the osmotic pressure across the
membrane and the cell swells (24).

Many cell types have mechanisms to limit osmotic swelling. The
degree to which a cell will take up solute during ATPase inhibition
depends on the permeability of the membrane to Na+, K+, and Cl'. In
toad bladder epithelial cells, for example, inhibition of the Na+/K+ATPase will lead to a secondary block of Na+ permeability which
prevents severe osmotic overload and cell rupture (45). Similarly, the
Na+/K+/Cl" cotransporter may function as an alternative pathway for
solute influx, and its inhibition may decrease the effect of ATPase
inactivation. This may be accomplished by an intracellular mecha¬
nism, or pharmacologically by loop diuretics such as furosemide,
bumetanide, or ethacrynic acid (45). Regulation of one transporter in
response to the altered functioning of another may thus serve as a
homeostatic volume control mechanism in cells that may experience
changes in their osmotic environment. This has been best characterized
in the diluting segment cells of the thick ascending limb of the loop of
Henle. These cells rapidly transport ions from their apical to basolateral
surfaces without significant volume changes. Blockade of the
Na+/K+/Cl" cotransporter by loop diuretics should lead to an abrupt
decrease in cell volume, assuming that K+ continues to leak out of the
cell while influx is halted, but actually no dramatic change in volume
was observed (24). The efflux of K+ must therefore have been suddenly
reduced to maintain a high [K+li and a constant volume (24). The
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complex series of interactions which adjusts and coordinates the
transporters is not understood, but it is clearly of great importance for
these epithelial cells to regulate their volume, and it is likely to be a key
regulator in many other tissues, especially contractile cells.

Vasoactive Agents and Potassium Transport

The regulation of potassium transport certainly plays a pivotal role
in the maintenance of high [K+]i, determination of membrane potential,
and control of cell volume. A vast amount of literature has attempted to
demonstrate that vasoactive agents influence K+ transport mechanisms
in many cell types. In mesangial cells, vasoactive agents may, via the
modulation of K+ transporters, modify cellular tension and volume,
thereby alter glomerular filtration, and ultimately affect systemic blood
pressure, serum electrolyte balance, and urine output.

Clinically important regulation of sodium and potassium balance
occurs in response to the mineralocorticoid, aldosterone. This hormone
stimulates the Na+/K+-ATPase, as well as Na+ and K+ channels, in the
cells of the distal nephron (80). Alternatively, atrial natriuretic peptide
has been shown to inhibit the ATPase in several cell types (52,68), and
appears to oppose the effect of aldosterone in vivo. AVP, ANG II, and
norepinephrine have been shown to cause indirect stimulation of the
ATPase in vascular smooth muscle cells (7,55,71). The stimulatory
effect of ANG II on the ATPase was demonstrated in renal cortical
tubules (56), and AVP stimulated the ATPase in rat medullary thick
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ascending limb cells as well (10). It is unclear whether these agents
have a direct effect on the Na+/K+-ATPase or if they cause an increase
primarily in intracellular Na+ concentration which then secondarily
stimulates the ATPase (71). Modulation of the ATPase also appears to
have an effect on the cell's response to these vasoactive agents. Inhibi¬
tion of the ATPase enhances the vascular contraction induced by A VP,
ANG II, and norepinephrine in smooth muscle (55,71), and the effect of
bradykinin on atrial endothelial cells was also augmented by ATPase
inhibition (42). Although there is a vast literature on the Na+/K+ATPase, relatively little is known about its regulation by vasoactive
agents in mesangial cells.

The effect of vasoactive agents on the Na+/K+/Cl‘ cotransporter
seems to vary according to each individual tissue or cell type. In
vascular smooth muscle cells, ANG II and ANP have both been demon¬
strated to stimulate the cotransporter (54,59,72).

In endothelial cells,

however, cotransport is increased by ANG II and decreased by ANP (52).
Furthermore, the intracellular signals involved in the coupling of
receptor-binding to modulation of transport also appear to differ among
various cell types. Elevation of cyclic adenosine monophosphate (cAMP)
will stimulate cotransport in avian erythrocytes (60) but inhibit it in
mammalian erythrocytes (23). Cyclic guanosine monophosphate
(cGMP), calcium, and protein kinase C (PKC) have also been implicated
in signal transduction for Na+/K+/Cl' cotransporter regulation, and
appear to exert different effects in different cell types (17,54,57,59).
Serotonin (5-hydroxytryptamine, 5-HT) has been noted to activate
adenylate cyclase and therefore increase cAMP levels in the guinea pig
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hippocampus and in blowfly salivary gland tissue, but to inhibit the
cyclase in rat hippocampus (64). Multiple receptor subtypes are known
for this neurotransmitter and may explain the diversity of its effects on
cAMP levels (64), but its effects on the Na+/K+/Cl" cotransporter are not
established.

Homma et al. (31) have recently demonstrated the presence of the
loop diuretic-sensitive Na+/K+/Cl' cotransporter in rat MCs using
radioactive rubidium flux measurements. Their experiments demon¬
strated further that the cotransporter was stimulated by ANG II, AVP,
and ANP (31). Increased intracellular cAMP levels inhibited the
Na+/K+/Cl' cotransporter in MCs, while PKC caused transient stimula¬
tion of cotransport followed by significant inhibition (30). Homma and
Harris (30) speculate that this biphasic response of the cotransporter
may reflect undetected changes in the intracellular ionic environment,
such as a response to redistribution of transported ions or alteration of
cell volume. The 86Rb+ flux method, however, does not provide a
method for continuous monitoring of intracellular ion concentrations,
and the precise sequence of events cannot be determined.

The effect of vasoactive agents on K+ channels and conductance is
not well understood, nor is the relationship between Em and vasoactive
agent-induced contraction of smooth muscle cells. In arterial smooth
muscle, norepinephrine will induce an increase in tension without a
change in Em at low doses, but at higher doses will cause depolarization
with increasing tension (8). The threshold dose for depolarization varies
among different species (26). In addition, the permeability of the
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membrane to ions such as Na+> K+, and Cl' may be altered by either
direct or indirect effects of norepinephrine (8,14). Total ionic conduc¬
tance of the cell to potassium might then be increased to prevent any
significant net depolarization. This is further confounded by the
observations that 5-HT, a known stimulus for smooth muscle contrac¬
tion, has been observed to either increase or decrease K+ conductance in
various cell types (18,64). Bradykinin, a potent vasodilator, is consistent
in that it increases the K+ permeability and hyperpolarizes renal
epitheloid cells (41), as well as aortic endothelial cells (12). ANP also
relaxes the vasculature, yet it has been found to hypopolarize renal
medullary collecting duct cells by inhibition of Na+ channels rather
than altering K+ conductance (43). Ultimately, the effect of a vasoactive
agent on mechanical coupling by either an electrical or pharmacological
mechanism appears to depend primarily on the particular contractile
tissue studied and the species from which it was derived (26). This
again points to the complexity of the regulation of ion transport, and the
need to evaluate these mechanisms in each unique cell type.

Previous studies in mesangial cells have investigated the effects of
vasoactive agents on membrane potential and chloride conductance.
Em was found to range from about -45 mV to -53 mV (40,47,58). ANG II
and AVP were demonstrated to stimulate a calcium-activated Cl'
conductance and depolarize the MC membrane (40,58). However, the
influence of other vasoactive agents on this and other ion transport
mechanisms remains to be investigated.
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Measurement of Intracellular Potassium

Few methods exist for evaluating K+ transport in intact living cells
over a continuous time period. Many studies have employed methods
which require destruction of the cells at particular timed intervals, such
as flame photometry, atomic absorption, and 86Rb+ flux analysis. The
loss of temporal resolution presents a major drawback to these methods
when rapid changes (on the order of seconds) occur in the ionic environ¬
ment. Furthermore, 86Rb+ may not substitute exactly one-to-one for
potassium in all transport pathways (73). Nuclear magnetic resonance
studies are nondestructive but require large quantities of tissue to be
placed in a magnet cavity which may limit access for manipulation, and
are also extremely costly (49). Impalement with K+-sensitive micro¬
electrodes has thus far been of limited applicability in many types of
small eukaryotic cells because of technical difficulty (1).

The recent development of the K+-sensitive fluorescent dye,
potassium-binding benzofuran isophthalate (PBFI), has provided a noninvasive technique for determining [K+li in MCs under both steady-state
and transient conditions with excellent temporal resolution. As synthe¬
sized by Minta and Tsien, PBFI fluoresces differentially in the presence
of varied [K+] but is less affected by other ions such as Na+ and H+ (49).
Fluorescent dyes have been used extensively to measure intracellular
pH and calcium concentration in MCs (5,19,20,22,78,79), as well as
membrane voltage and intracellular concentrations of sodium and
magnesium in other cells (28,49,50,56).
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We examined [K+]j using the fluorescent technique to further our
understanding of mesangial cell ion transport processes. The purposes
of this study were: 1) to examine the spectral properties of PBFI, 2) to
obtain an intracellular calibration of [K+li with the dye in mesangial
cells, and 3) to investigate the mechanisms of potassium transport in
these cells. We sought to establish that by using this fluorescent
technique, fluctuations in [K+]i during specific experimental maneu¬
vers could be measured in MCs, and would be useful in showing the
presence of multiple transport pathways for K+ and their interrelation.
We measured [K+li continuously under control conditions and during
selective inhibition of putative K+-cotransporters, exchangers, and
channels (36). The effect of several vasoactive agents on K+ flux in these
unique cells was also examined.
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METHODS

Culture of Mesangial Cells

Isolated glomeruli from young male rat kidneys were obtained by
differential sieving and harvesting from a wire mesh. Glomeruli were
then digested with collagenase to remove epithelial cells, leaving cores
which consisted predominantly of mesangial cells, matrix, and
capillary loops (44,48). The cells were grown in Dulbecco's Modified
Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS), 5
H-g/mL insulin, 5 (ig/mL transferrin, 5 ng/mL selenous acid, 10 mM Lglutamine, 25 mM glucose, 400 ng/mL penicillin, 500 ng/mL strepto¬
mycin, and 25 mM HCO3'. In this medium, MCs grew readily while
other glomerular cells did not survive (44,48). MCs proliferated to form
confluent monolayers (i.e., one-cell-thick layers, with each cell in
contact with neighboring cells) and were subsequently suitable for
passage of subcultures.

Routine examination of the cultured cells, to confirm their identity
as MCs, was performed by indirect immunofluorescence microscopy
using rabbit immunoglobulin G (IgG) directed against vascular smooth
muscle myosin and fluorescein isothiocyanate (FITC)-conjugated mouse
IgG directed to rabbit IgG. Cells showed uniformly strong positive
staining of longitudinal filaments, a pattern that is characteristic of
MCs (77). In addition, cultured cells stained uniformly with anti-Thy
1.1, which is also considered to be indicative of MCs (22).
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Our studies employed subcultures of the third to eighth passage of
MCs grown on glass cover slips at 37°C in 5% 002*95% air. The cells
were suitable for experimentation after 10-14 days of growth in culture
on the the cover slips, shortly before reaching confluence. Twenty-four
hours prior to potassium fluorescence measurements, the medium was
changed from 10% to 0.5% FBS to halt cell growth and facilitate
subsequent dye-loading.

Fluorescent Measurement of Intracellular Potassium

[K+li was determined by use of the K+-sensitive dye potassium¬
binding benzofuran isophthalate (PBFI). The cell-permeant acetoxymethyl ester (AM) form of the dye was dissolved in dimethyl sulfoxide
(DMSO) to a stock concentration of 5 mM and then diluted to 5 pM in
saline. The detergent Pluronic F-127 enhances dye-loading, and was
added to the dye mixture to make a 0.04% (w/v) solution. Serum-starved
MCs on cover slips were incubated with the dye mixture for 90 min at
37°C. The cells were then washed with standard saline solution and
placed in a thermostatically controlled (37°C) polystyrene cuvette in a
Perkin-Elmer LS-5B spectrofluorometer (Norwalk, CT). The AM ester is
hydrolyzed within the cell to yield the impermeant, polyanionic, In¬
sensitive PBFI free acid form, which exhibited an excitation maximum
at 340 nm and an emission maximum at 500 nm (excitation slit width
was 3 mm, emission slit width was 5 mm). The fluorescent signal
recorded was the summation of luminescences from all cells in the light
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path. Continuous perfusion of the cuvette with the standard saline
solution removed extracellular PBFI and minimized any interference by
dye leakage into the extracellular space.

As shown in the series of excitation spectra (Figure 1), the fluores¬
cence of the dye was particularly sensitive to [K+]i when excited at 340
nm, but was relatively unaffected by varied [K+]i upon excitation at the
isosbestic point near 380 nm. The ratio of the luminescences, obtained
by exciting the cells at these wavelengths (340 nm/380 nm) while
measuring at a constant emission at 500 nm, was thus indicative of
[K+li yet undisturbed by other parameters such as number of cells in the
light path and dye leakage from the cells. Background noise contributed
to less than 10% of the signal in dye-loaded cells, and agonists and
antagonists contributed to less than 10% of the total fluorescence
throughout all experiments. Autofluorescence of cells, solutions, and
antagonists was corrected for in all experiments. Furthermore,
luminescences obtained from excitation at both 340 and 380 nm declined
minimally (by less than 15%) during an average 10-20 minute experi¬
ment, yet the ratio remained constant despite these changes. This most
likely represents photobleaching and did not influence determinations of
[K+li since the ratio was not affected.

Prior analysis of PBFI by the manufacturer has demonstrated that
dye is not completely selective for K+, but also has affinity for Na+ and
H+ ions (49). In order to ascertain the contribution of Na+ to fluores¬
cence, we preincubated MCs with monensin and nigericin and then
exposed the cells to varying concentrations of Na+ (replaced with N-
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Figure 1. Fluorescence excitation spectra of PBFI in MCs as a function
of [K+]i. These spectra were obtained in various calibration solutions as
described in Methods. Emission wavelength was set at 500 nm.
Excitation maximum occurred near 340 nm, and a relatively [K+hinsensitive isosbestic point occurred near 380 nm. The values of
extracellular [K+] (in mM) are indicated above their respective spectra.
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methyl-D-glucamine as necessary to maintain a constant osmolarity)
and recorded the fluorescent intensity of the dye. This method, like the
calibration which follows, should clamp intracellular Na+ concen¬
tration ([Na+]i) to the known extracellular Na+ concentration (28). The
fluorescence of the dye was not significantly affected by [Na+]i of 5, 50,
and 75 mM (n=3 each, data not shown). At higher levels of [Na+]i, PBFI
fluorescence did increase by 27% when [Na+]l was 100 mM, and by 34%
when [Na+]l was 150 mM (n=3 each, p<0.05). These results suggest that
the sensitivity of PBFI for changes in [K+]i are only likely to be signifi¬
cantly and adversely affected by an extraordinarily high [Na+]i.

In order to confirm that PBFI was not affected by intracellular pH
(pHj), MCs were subjected to an acid load by ammonium pulsing
(NH4+/NH3) and allowed to recover spontaneously (as described
previously (5,19)). No significant changes in fluorescence were detected
during these acute acid-base perturbations at pHj values of 6.6, 7.0, 7.2,
and 7.8 (n=3 for each value of pHi, data not shown) PBFI therefore
retains its sensitivity to K+ in the face of wide variations in pHi.

Experiments involving manipulation of ion transporters and [K+]i
may also cause transient changes in cell volume, which may conse¬
quently alter the properties of the dye. To assess the effect of large and
rapid volume changes on PBFI fluorescence, we altered extracellular
osmolarity of the MC bathing solution from 200 mM to 500 mM by the
addition of sucrose. Within this range, no significant changes in
fluorescence were noted (n=3 for each). At higher extracellular osmo¬
larity, however, the fluorescence ratio of the dye increased, by 8% at 550
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mM, 15% at 600 mM, and 20% at 650 mM (n=3 each, p<0.05). These
osmolarities represent near doubling of the likely physiological range for
the cells, and these data indicate that the calibration of the dye may yield
unreliable values of [K+]i when cells experience severe osmotic distur¬
bances. In other words, factors which modify [K+]i by a direct mecha¬
nism on the K+ transporters may also alter cell volume, secondarily
resulting in a change in [K+]i. In this situation, it would not be possible
to distinguish between the direct and volume-related effects on [K+li.

Calibration of PBFI

PBFI was calibrated intracellularly by clamping [K+]i to known
values of [K+]0 using the ionophores valinomycin and nigericin. The
cyclic peptide antibiotic valinomycin, a K+-ionophore and mitochondrial
uncoupler, increased the permeability of the membrane to K+ and
depleted intracellular energy stores (74) while nigericin, a K+/H+
exchanger, equilibrated extracellular pH with intracellular pH (79). All
active ion transport was inhibited and K+ became distributed equally on
both sides of the membrane. Valinomycin and nigericin were initially
dissolved into ethanol to 1 mM stock and then diluted 1:1000 and 1:200 in
the calibration saline solutions, respectively. Cells were first dye-loaded
with PBFI and then incubated for 15 minutes in the presence of 1 |iM
valinomycin, 5 |iM nigericin, and varied [K+]0 in a calibration solution.
Assuming that [K+]i equalized to [K+]0 under these conditions, a
standard curve was generated by plotting the fluorescence ratio against
[K+]i. Whole cell patch-clamp experiments support the validity of this
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method. They confirm that the membrane potential approaches zero
when MCs are incubated with valinomycin and nigericin (unpublished
observations by R.M. Henderson and R. Unwin at the Royal
Hammersmith Hospital, U.K.).

As the fluorescence intensity of the dye depends on [K+]i in the same
manner as the activity of an enzyme does on substrate concentration, a
nonlinear least squares fit of the data to the form of the MichaelisMenten equation was performed:

I340
-

I38o

[K+li
=

Imax

+

lo

[K+]i + KM

where I340/I38O is the measured fluorescence ratio, Io indicates the mini¬
mal ratio (as [K+]i goes to zero), the sum of Imax and Iq represents the
maximal ratio (as [K+li approaches infinity), and Km is the MichaelisMenten constant that reflects the affinity of the dye for K+. The curve
fitting analysis determined the values of Io = 2.29 and Imax = 3.93 with a
Km equal to 113 mM (n=40, r=0.998, Statistical Analysis System, Yale
Computer Center) (See Figure 2). The calibration curve thus generated
was used in all experiments to determine the values of [K+li from the
measured 340 nm/380 nm fluorescence ratios in PBFI-loaded glomeru¬
lar mesangial cells.
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Figure 2. Calibration Curve. The dependence of the fluorescence ratio
(340 nm/380 nm) on [K+] was fit to the Michaelis-Menten equation
(nonlinear least squares fit, r=0.998, n=40) with Km determined to be 113
mM. Five samples were measured for each value of [K+]0, and standard
error bars are indicated about the means (x).
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Data Analysis

Tracings of [K+]i (Figures 3-6) are actual recordings of fluorescence
when the cells are excited at 340 nm, but data were evaluated via the
calibration curve (Figure 2). [K+li is reported as a mean ± standard
deviation, and statistical significance was determined by paired t test or
analysis of variance. Results were considered to be significant when
p<0.05.

Solutions

The standard saline solution contained (in mM) 145 Na+, 5 K+, 150
Cl", 1.0 Mg2+, 1.8 Ca2+, 1.0 PO^-, 10.0 glucose, and 32.2 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) and was titrated to a
pH of 7.40. Calibrating solutions containing valinomycin and nigericin
were prepared in the same standard saline buffer, but K+ and Na+ were
varied such that the sum of [K+]0 and [Na+]0 was maintained at 150
mM. Ouabain was used to inhibit the Na+/K+-ATPase and was
dissolved in standard saline to a final concentration of 0.5 mM.
Furosemide and ethacrynic acid antagonize the activity of the
Na+/K+/Cl" cotransporter, and were made up as 10 mM stock solutions
in DMSO and were diluted in standard saline to 10 pM for application to
the cells. Barium (0.5 mM) and TEA (10 pM) were used to block K+
conductance and were dissolved in the standard solution, except the
barium solution was made without phosphate. These substances were
used alone and in combinations with each other in these studies to
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separate the roles of each transporter on [K+]i homeostasis.
Angiotensin II (1 pM), serotonin (10 pM), atrial natriuretic peptide (100
nM), and bradykinin (1 pM) were all dissolved in the standard saline
solution on the day of the experiment. The fluorescence of each of these
agents in solution, if significant, was subtracted from the fluorescence
measurements of the PBFI-loaded MCs. The solvents, DMSO and
ethanol, had no effect on fluorescence measurements or determinations
of[K+]i.

Materials

PBFI/AM, Pluronic F-127, and valinomycin were obtained from
Molecular Probes (Eugene, OR). Furosemide, ethacrynic acid,
angiotensin II, bradykinin, serotonin, barium, nigericin, ouabain,
monensin and plastic cuvettes were purchased from Sigma (St. Louis,
MO). Atrial natriuretic peptide (human 1-28) was purchased from
Peninsula Laboratories (Belmont, CA). DMEM, FBS, penicillin,
streptomycin, were obtained from GIBCO Laboratories (Grand Island,
NY). Anti-Thy 1.1 was purchased from Chemicon (Temecula, CA).

Personnel / Technical Assistance

The sacrifice of rats, isolation of glomeruli, and preparation of
primary MC cultures were performed by M.B. Ganz and M.C. Perfetto.
MCs were stained by P. Dann for the purposes of identification. Pre-
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paration of passages 2 through 8, plating of MCs on cover slips, and
routine maintenance of MCs were done by S.E. Kasner. All culture
media were prepared by M.C. Perfetto.
The protocol for PBFI dye-loading, method for calibration, and
experimental design for all fluorescence measurements were developed
by S.E. Kasner. All determinations of fluorescence ratios and [K+]i were
performed by S.E. Kasner. M.B. Ganz assisted in the acid-loading
experiments used in the assessment of the effect of pH on PBFI.
Statistical analysis was performed by S.E. Kasner. The calibration
data were analyzed for curve fitting on the Statistical Analysis System
(Yale Computer Center) with the assistance of J. Goffinett.
All solutions used in experiments were made by either S.E. Kasner
or M.B. Ganz. The continuous perfusion apparatus was designed and
constructed by S.E. Kasner.
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RESULTS

Mechanisms of Potassium Homeostasis

[K+Ji in MCs. The resting level of [K+]j in MCs, pooled from all
experiments, was determined to be 102 ± 7 mM (n=81). The 340/380 nm
fluorescence ratio, and therefore [K+]i, remained relatively constant for
at least 30 min during all static experiments, regardless of any photobleaching or leakage of dye from the cells. None of the experiments in
this study required a time period longer than 30 minutes.

Na+ /K+ ATPase. This laboratory has previously demonstrated that
rat MCs express the alpha subunit for the Na+/K+ ATPase (63). The
physiological activity of the Na+/K+ ATPase was assessed here by
inhibiting with ouabain. Concentrations as low as 10 pM ouabain led to
a significant decrease in [K+]i in MCs without evidence of return toward
initial [K+]i. A maximal fall in [K+]i occurred at ouabain concentra¬
tions of 0.5 mM or greater. In MCs exposed to 0.5 mM ouabain, [K+]i
declined to 48 ± 6 mM (n=8, p<0.01) within 2.9 ± 0.9 min (Figure 3). At no
time in the continued presence of ouabain was any recovery of [K+]i back
toward the initial steady-state value observed, implying that there was
not an ouabain-insensitive mechanism that could maintain [K+]i
homeostasis when the Na+/K+-ATPase was disabled.

Na+ /K+1 Clm cotransporter. We determined the activity of the
Na+/K+/Cl' cotransporter through the use of two antagonists, the loop-
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diuretics furosemide and ethacrynic acid. As shown in Figure 4A,
when MCs were exposed to 10 }iM furosemide, there was a rapid drop in
baseline [K+]i to 58 ± 11 mM, a 43% decrease (n=16, p<0.01) within 1.2 ±
0.5 min (Figure 4A). The decrease in [K+]i was followed by a return to
near baseline [K+]i within 5.0 ± 1.2 min in the continued presence of
furosemide. Furthermore, when MCs were exposed acutely to
furosemide and then to 0.5 mM ouabain, the recovery was completely
abolished. These experiments suggest that the Na+/K+ ATPase plays a
major role in the recovery of [K+]i to near steady-state levels in the
presence of furosemide. We sought to additionally confirm the presence
of the Na+/K+/CT cotransporter in MCs using ethacrynic acid, since
this antagonist to the cotransporter is minimally fluorescent at these
same wavelengths and thus required no mathematical correction. In a
manner similar to that of furosemide, MCs exposed to 10 pM ethacrynic
acid exhibited a fall from initial [K+]i to 63 ± 9 mM, a 38% decline (n=13,
p<0.01) in 1.9 ± 0.6 min, that was followed by a return to near baseline
[K+]i in 4.1 ± 0.9 min (Figure 4B). In the continued presence of
ethacrynic acid, the application of ouabain completely prevented the
recovery of [K+]j to original levels. The difference between the effects of
furosemide and ethacrynic acid was not significant.

K+ conductance pathways. In order to determine whether the
presence of a K+ conductance can be shown using PBFI, known blockers
of K+ channels, barium and TEA, were employed. In MCs exposed to
barium, [K+]i rapidly increased from the baseline value to 124 ± 8 mM
(n=9, p<0.01) (Figure 5). The sudden increase in [K+]i was followed by a
prompt return to near baseline within 3.9 ± 0.7 min. This barium-
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Figure 3. Effect of ouabain on [K+]i. Ouabain (0.5 mM) was added
directly to the cuvette. [K+]j fell to an average of 48 ± 6 mM (p<0.01). No
recovery was observed in the continued presence of ouabain. This
tracing is a representative of 8 experiments.

furosemide

B.

[K*]. (mM)

Figure 4. Effect of diuretics on [K+]i. A: Effect of furosemide. [K+]i
declined to an average of 58 ± 11 mM (p<0.01). In the continued presence
of furosemide, [K+]i returned toward near baseline levels. Exposure to
ouabain completely prevented the recovery. This tracing is a
representative of 16 experiments. B: Effect of ethacrynic acid. [K+]i
declined to an average of 63 ± 9 mM (p<0.01). In the continued presence
of ethacrynic acid, [K+]i returned toward near baseline levels. Exposure
to ouabain completely prevented the recovery. This tracing is a
representative of 13 experiments.

Barium

Figure 5. Effect of barium (Ba2+) on [K+h. [K+]j increased to an average
of 124 ± 8 mM (p<0.01). In the continued presence of Ba2+, [K+h
returned toward near baseline levels. This tracing is a representative of
9 experiments.
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induced increase in [K+]i was prevented when the cells were preincu¬
bated with both ouabain and furosemide (n=5, non-significant difference
from baseline, data not shown). When MCs were exposed to TEA there
was a similar increase in [K+]i to 123 ± 10 (n=8, p<0.01), which was
followed by a return to near baseline (data not shown).

Effect of Vasoactive Agents

[K+]i in MCs. MCs were treated with the vasoactive substances,
angiotensin II, serotonin (5-hydroxytryptamine), bradykinin, and atrial
natriuretic peptide at the concentrations stated above as a single pulsed
dose. These agonists did not induce any significant change in the
resting level of [K+]i in MCs, either acutely or during the 10 min
following initial exposure (data not shown); [K+]i remained at the
preagonist level of 103 ± 6 mM (n=16, four experiments for each agonist
tested).

Na+ /K+-ATPase. The recovery of [K+]i following treatment of MCs
with furosemide or ethacrynic acid is attributed to continued function¬
ing of the Na+/K+-ATPase. As a means of assessing the kinetics of the
Na+/K+-ATPase, we determined a recovery rate in the presence of
ethacrynic acid defined as the rate of increase in [K+]i over a 10 s
interval, measured at the point of reference when [K+]i was 70 mM. The
influence of ANG II, 5-HT, BK, and ANP on the activity of the Na+/K+ATPase was evaluated by comparison of these rates. In the absence of
other modifiers, ethacrynic acid transiently caused [K+]i to fall as
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described above, and subsequently returned toward original levels at a
rate of 2.9 ± 0.4 mM/10 s (n=6). Pretreatment with ANG II, 5-HT, and
BK significantly stimulated recovery velocities when compared to this
control, but no significant differences between any two of these agents
were noted: ANG II increased the rate to 3.7 ± 0.4 mM/10 s (n=6, p<0.01,
Figure 6A), 5-HT to 4.1 ± 0.7 mM/10 s (n=6, p<0.01), and BK to 3.6 ± 0.4
mM/10 s (n=6, p<0.01). ANP exhibited no effect on the recovery phase
(rate was 3.0 ± 0.2 mM/10 s, n=6, NS, Figure 6B) (See Table 1).

Na+ /K+ / Cl~ cotransporter. The influence of these vasoactive agents
on the Na+/K+/Cl' cotransporter was more difficult to assess. MCs were
not able to restore K+ homeostasis in the presence of ouabain in a
manner analogous to their recovery from loop diuretics. This precluded
the direct evaluation of the kinetics of the cotransporter in response to a
fall in [K+]i. As an alternative means of evaluation, we sought to
compare the effects of vasoactive factors on the fraction of K+ uptake that
could be attributed to the Na+/K+/Cl' cotransporter. As described above,
ethacrynic acid applied to MCs caused a precipitous fall in [K+]i to 63 ± 9
mM, and thus we inferred that 38% of steady-state [K+]i was maintained
by the cotransporter. In MCs preexposed to ANG II, ethacrynic acid
caused a significantly greater decline to 42 ± 6 mM (n=6, p<0.01). MCs
treated with 5-HT demonstrated an increased sensitivity to ethacrynic
acid of similar magnitude, as [K+]i fell to 45 ± 8 mM (n=7, p<0.01). The
effect of BK was not significant, with [K+]i decreasing to 56 ± 7 mM (n=6,
NS), and ANP also appeared to have no influence on the cotransporter
([K+li was 60 ± 4 mM, n=7, NS) (See Table 2).
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A.

B.

Figure 6. Effect of vasoactive agents on recovery from an ethacrynic
acid-induced fall in [K+]i. A: Effect of angiotensin II (ANG II).
Pretreatment with ANG II increased the rate of recovery to 3.7 ± 0.4
mM/10 s, a 28% increase compared to the control rate of 2.9 ± 0.4 mM/lOs
(p<0.01). B: Effect of atrial natriuretic peptide (ANP). Pretreatment with
ANP caused no significant change in the rate of recovery (3.0 ± 0.2
mM/lOs) when compared to control. Each tracing is a representative of
6 experiments.
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EFFECT OF VASOACTIVE AGENTS ON THE
Na+/K+-ATPase

Rate of
Recovery
(mM/lOs)

Percent
Increase

control

2.9 ± 0.4

—

ANG II

3.7 ±0.4*

28 %*

5-HT

4.1 ±0.7*

41 %*

BK

3.6 ±0.5*

24 %*

ANP

3.0 ±0.2

3%

Table 1. Effect of the vasoactive agents on the Na+/K+-ATPase. This was
determined as the rate of recovery of [K+]i in the presence of ethacrynic
acid. Significant differences (p<0.01 by analysis of variance) from control
rates are indicated with an asterisk ().
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EFFECT OF VASOACTIVE AGENTS ON THE
Na+/K+/Cl- COTRANSPORTER

[K+]i
after EA
(mM)

Fractional
Contribution
to [K+]i

Percent
Increase

control

63 ± 9

38 %

ANG II

42 ±6*

59% *

55 %*

5-HT

45 ±8*

56 %*

47 %*

BK

56 ±7

45 %

18%

ANP

60 ±4

41 %

8%

—

Table 2. Effect of the vasoactive agents on the Na+/K+/CT cotransporter.
This was calculated as the fractional contribution to [K+]i maintenance
that was inhibited with ethacrynic acid (EA) (i.e. the maximal EA-induced
change in [K+]i from the initial value, divided by the initial value of [K+]i).
Significant differences (p<0.01 by analysis of variance) from control rates
are indicated with an asterisk (*).
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DISCUSSION

Analysis of PBFI

This is the first cellular application of which we are aware for the
new fluorescent potassium indicator, PBFI. In a previous report, this
dye had been used in liposomes, and the calibration method did not
utilize fluorescence excitation ratios (34). We were able to characterize
the properties of the dye in cells, as well as examine and discern some of
the major K+ transport mechanisms in mesangial cells and their
response to several vasoactive agents.

Our experiments demonstrated that fluorescence of PBFI was not
significantly affected by acute changes in pHi from 6.6 to 7.8, alterations
in intracellular Na+ concentrations when [Na+]i was less than 75 mM,
nor changes in osmolarity from 200 to 500 mM. The use of the ionophores, valinomycin and nigericin, proved to be a valid method for cali¬
bration of dye fluorescence ratios in the determination of [K+]j. Our
results further indicate that PBFI is reasonably well-suited for the
continuous monitoring of rapid changes in K+ homeostasis in whole
cells. We have also shown that the net effect of various K+ transporters
on [K+]i may be assayed both individually and collectively.

The fluorescent technique offers a number of distinct advantages
over other methods in the examination of ion transport. It provides a
continuous rather than interval record of the changes in [K+]i, elimi-
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nates the need for radioisotopes, and is extremely sensitive within the
likely physiological range of [K+]i (50-120 mM). It is a technically simple
and inexpensive method that does not require the extensive apparatus or
skill such as that necessary for intracellular electrophysiological
measurements.

The usefulness of the dye may be limited by several parameters. 1)
Many of the agents used to inhibit the K+ transporters are fluorescent to
some degree, and although interfering fluorescence has been subtracted
from all experiments, some extremely transient alterations in [K+]i may
be masked by extraneous changes in fluorescence. 2) The resolution of
the dye for [K+]i above the physiological range is greatly diminished. At
levels of [K+]i greater than 130 mM, the calibration curve (Figure 2)
flattens, and thus the sensitivity of the dye decreases dramatically: a
small error in the measurement of a fluorescence ratio would result in a
large error in the determination of [K+]i. Measurements of high [K+]i
are therefore likely to be inaccurate. In our experiments, we did not
measure increases in [K+]i above 130 mM in MCs. 3) The effect of
alteration in cell volume on the calibration of PBFI is ill-defined. While
the dye does not appear to exhibit significant change in its fluorescent
properties when osmolarity is changed, this does not negate the
possibility that an acute volume shift may cause a secondary effect on
the measured value of [K+]i.

PBFI is clearly not optimal for all investigations of [K+]i. A more
quantitatively precise K+-sensitive dye must demonstrate greater
selectivity for K+ over Na+. It should have longer excitation maximum
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and isosbestic wavelengths in order to minimize the effects of cell and
reagent fluorescence, thereby increasing the signal-to-noise ratio.
Finally, it should have a higher value of Km to improve the resolution of
[K+]i at levels greater than 130 mM. Nonetheless, PBFI provides a vast
improvement in noninvasive continuous potassium measurement in
cultured cells, and promises to be useful for physiological measure¬
ments in many systems.

Regulation of [K+]i in Mesangial Cells

The properties of the PBFI allow us to examine [K+]i under basal
and stimulated conditions. Moreover, these experiments demonstrate
that real time changes in intracellular potassium concentrations in
mesangial and other cells may be measured using PBFI. Our deter¬
mination of resting [K+]i to be 102 ± 7 mM in MCs concurs with results
obtained recently by preliminary patch-clamping experiments in MCs
(R.M. Henderson and R. Unwin, unpublished observations). The
results also confirm ongoing work by Homma et al. (31), demonstrating
that MCs possess at least two mechanisms for K+ uptake, the Na+/K+ATPase and the Na+/K+/Cl' cotransporter. As measured in intact
quiescent MCs in vitro, we found that the ouabain-sensitive component
of K+ uptake is responsible for maintaining 53% of [K+]i and the
furosemide-sensitive component for 43%. Thus, it appears that these
two transport mechanisms can account for nearly all of K+ uptake in
MCs. These findings are also consistent with those of Homma et al. (31),
in which 46% of 86Rb+ uptake was shown to be mediated by the Na+/K+-
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ATPase and 24% by the furosemide-sensitive Na+/K+/Cl' cotransporter.
Furthermore, it is clear that MCs can recover from the inhibitory effect
of furosemide on the cotransporter, via the activity of uptake pathways,
i.e., the Na+/K+-ATPase, but they are unable to maintain [K+]j
homeostasis if the ATPase is inhibited by ouabain. The operation of the
Na+/K+-ATPase, as a primary active transport mechanism, is therefore
deemed to be a prerequisite for K+ transport in MCs, but its quantitative
role in K+ uptake appears to be interrelated with the activity of the
Na+/K+/Cl' cotransporter.

The effects of the vasoactive agents on K+ transport mechanisms in
MCs defy easy categorization. The Na+/K+-ATPase is shown to be
stimulated by the vasoconstrictors, ANG II and 5-HT, in MCs recover¬
ing from an acute (diuretic-induced) drop in [K+Ji. However, the
ATPase is also stimulated by BK, a vasodilator, but not by ANP. ANP is
often considered to be an inhibitor of the ATPase (52,68), but here no
significant effect was recorded. The physiological importance of these
data are somewhat unclear, given the observation that both vasocon¬
strictive and one of the vasorelaxant substances led to stimulation of the
Na+/K+-ATPase. However, the ATPase is generally not thought to play
a major part in volume regulation (69). Rather, the activity of the
Na+/K+-ATPase has been shown to be secondarily augmented in many
volume regulatory responses to osmotic stimuli, presumably in response
to increased [Na+]i from other pathways, and may serve only a support¬
ive role in [K+]i and [Na+]i homeostasis (17,55,69,71). We therefore
needed to examine the influence of the vasoactive agents on the other K+
flux mechanisms.
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The activity of the Na+/K+/Cl' cotransporter in MCs was dramati¬
cally increased by ANG II and 5-HT. Thus, the vasoconstrictors
stimulated both the ATPase and the cotransporter, suggesting a close
relationship between these transporters in maintaining [K+]i and in
regulating cell shape and volume. BK stimulated the Na+/K+-ATPase
while ANP had no effect, but neither of these vasodilators exerted any
significant influence on the Na+/K+/Cl‘ cotransporter in MCs.

A

difference thus exists between the effects of constrictors and dilators on
the cotransporter. This suggests that the cellular mechanisms for
contraction and relaxation in response to these vasoactive agents may be
coupled to their effects on the Na+/K+/Cl' cotransporter, but perhaps not
to the Na+/K+-ATPase. In addition, a distinction can be made between
the effects of the two vasodilators examined here. BK stimulated the
Na+/K+-ATPase but not the Na+/K+/Cl* cotransporter, whereas ANP
had no significant effect on either, implying that peptide-induced
relaxation of MCs may be mediated through more than one biochemical
pathway. These results imply greater complexity of K+ transport
regulation in MCs than had been previously realized.

Previous studies have utilized 8f>Rb+ flux measurements to show
that ANG II stimulates the Na+/K+/Cl" cotransporter in MCs (31) and
in vascular smooth muscle cells (53,54,59,72), but BK has also been
demonstrated to increase the activity of the cotransporter in endothelial
cells (6). In addition, some of these flux studies have also shown ANP to
exert a stimulatory effect on the cotransporter in smooth muscle (53,54),
but not in endothelial cells (52). The discrepancy between our results in
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mesangial cells compared to those in vascular smooth muscle and
endothelial cells is at present unclear. Mesangial cells are unique,
however, in that they share several morphologic features with both
smooth muscle and endothelial cells, and they lie in a position of direct
contact with the endothelium at particular sites in the glomerular
capillary loop (48). The data presented here suggest that MCs manifest
a composite of the properties of these two cell types with regard to their
potassium transport regulatory processes as well.

PBFI also allows us to demonstrate the presence of K+ channels in
MCs. K+ conductance pathways in MCs were blocked by treating the
cells with barium or TEA. The excellent time resolution of the dye
revealed a rapid 23% rise in [K+li when K+ channel blockers were
added. The effects of barium and TEA were indistinguishable from each
other. The abrupt and transient increase in [K+li appears to be a
consequence of continued functioning of the two major K+ influx
transporters during channel inhibition, since it was readily inhibited by
a combination of ouabain and furosemide. In addition, this rise in [K+]i
was halted and reversed spontaneously, such that it may be presumed
that some currently undefined feedback mechanisms must slow K+
influx and/or activate other efflux pathways in MCs. The presence of
other mechanisms for K+ transport is suggested by indirect evidence, as
MCs are capable of restoring [K+]i to initial levels when channels are
blocked by barium and TEA. This may represent alternative regulation
via barium/TEA-insensitive K+ channels, activation of K+/C1" cotrans¬
port (K+ exit), opening of Cl' channels (57), and/or additional modula¬
tion of the Na+/K+-ATPase and the Na+/K+/Cl' cotransporter. Both
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barium and TEA are known to be nonspecific K+ channel blockers,
particularly at high concentrations, and examination of the properties of
the specific types of K+ channels in MCs is a necessary part of future
examinations. However, this is likely to require a more direct channel
evaluation by an alternative method such as patch-clamping, since
determinations of whole cell [K+]i are likely to be obscured by simulta¬
neous fluctuations induced by the other K+ transporters. The role of
these K+ channels in MC contraction and relaxation in response to
vasoactive agents also awaits further investigation.

The concerted regulation of K+ flux pathways appears to be of vital
importance in MCs. Under steady-state conditions, MCs closely
maintain [K+]i at a constant level with significant contributions from
the Na+/K+-ATPase, the Na+/K+/Cl' cotransporter, and K+ conduc¬
tance pathways. While categorization of the effects of the vasoactive
agents on K+ transport is difficult, certain conclusions can be reached.
[K+]i is held at a constant level despite modulation of the K+ trans¬
porters by the vasoactive agents.

ANG II, 5-HT, and BK stimulated the

Na+/K+-ATPase, but only ANG II and 5-HT stimulated the Na+/K+/CP
cotransporter. Since no change in [K+]j was recorded during vasoactive
agent-induced stimulation of the K+ influx pathways, it is likely that
feedback and regulation of K+ efflux pathways occurs as well. In the
response to these substances, the Na+/K+-ATPase does not appear to be
a primary modulator of cellular shape change, however, since it fails to
react oppositely to vasoconstrictors and vasodilators. The Na+/K+/Cl'
cotransporter, on the other hand, seems to be stimulated by vasocon¬
strictors and is unaffected by vasodilators, suggesting a potential direct
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role for this transporter in MC contraction. The central mechanism for
the contraction or relaxation of MCs under the influence of these agents
may additionally be related to the regulation of K+ conductance via K+
channels. However, the specific regulation of K+ channels in MCs
requires further study. The intracellular biochemical signals that
coordinate and selectively activate or inhibit the individual K+ trans¬
porters in MCs also remain to be identified. These studies may be
facilitated by the use of the potassium-sensitive fluorescent dye, PBFI.

46

REFERENCES

1. AICKIN, D. C. AND A. F. BRADING. Advances in the
understanding of transmembrane ionic gradients and permeabilities in
smooth muscle obtained by using ion-selective micro-electrodes.
Experientia 41: 879-887, 1985.
2. APPEL, R. G., J. WANG, M. S. SIMONSON, AND M. J. DUNN. A
mechanism by which atrial natriuretic factor mediates its glomerular
actions. Am. J. Physiol. 251: F1036-F1042,1986.
3. AUSIELLO, D. A., J. I. KREISBERG, C. ROY, AND M. J.
KARNOVSKY. Contraction of cultured rat glomerular cells of apparent
mesangial origin after stimulation with angiotensin II and arginine
vasopressin. J. Clin. Invest. 65: 754-760, 1980.
4. BLANTZ, R. C., K. S. KONNEN, AND B. J. TUCKER. Angiotensin II
effects upon the glomerular microcirculation and ultrafiltration
coefficient of the rat. J. Clin. Invest. 57: 419-434, 1976.
5. BOYARSKY, G., M. B. GANZ, R. B. STERZEL, AND W. F. BORON.
pH regulation in single glomerular mesangial cells I. Acid extrusion in
absence and presence of HC03. Am. J. Physiol. 255: C844-C856, 1989.
6. BROCK, T. A., C. BRUGNARA, M. CANESSA, AND M. A.
GIMBRONE,JR. Bradykinin and vasopressin stimulate Na+/K+/Clcotransport in cultured endothelial cells. Am. J. Physiol. 250: C888C895,1986.
7. BROCK, T. A., L. J. LEWIS, AND J. B. SMITH. Angiotensin
increases Na+ entry and Na+/K+ pump activity in cultures of smooth
muscle from rat aorta. Pro. Natl. Acad. Sci. USA 79: 1438-1442, 1982.
8. CASTEELS, R., K. KITAMURA, H. KURIYAMA, AND H. SUZUKI.
Excitation contraction coupling in the smooth muscle cells of the rabbit
main pulmonary artery. J. Physiol. (London) 271: 63-79, 1977.
9. CELIO, M. R. AND T. INAGAMI. Angiotensin II immunoreactivity
coexists with renin in the juxtaglomerular granular cells of the kidney.
Pro. Natl. Acad. Sci. USA 78: 3897-3900, 1981.

47

10. CHARLTON, J. A. AND P. H. BAYLIS. Stimulation of rat renal
medullary Na/K-ATPase by arginine vasopressin is mediated by the V2
receptor. J. Endocrinol. 127: 213-216, 1990.
11. CLAPHAM, D. E. Potassium and tissue excitability. In: The
Regulation of Potassium Balance, edited by D. W. Seldin and G.
Giebisch. New York: Raven Press, 1989, p. 57-88.
12. COLDEN-STANFIELD, M., W. P. SCHILLING, L. D. POSSANI,
AND D. L. KUNZE. Bradykinin-induced potassium current in cultured
bovine aortic endothelial cells. J. Membrane Biol. 116: 227-238, 1990.
13. COOK, N. S. The pharmacology of potassium channels and their
therapeutic potential. TIPS 9: 21-28, 1989.
14. DROOGMANS, G., L. RAEYMACKERS, AND R. CASTEELS.
Electro- and pharmacomechanical coupling in the smooth muscle cells
of the rabbit ear artery. J. Gen. Physiol. 70: 129-148, 1977.
15. DULING, B. R. Components of renal function. In: Physiology,
edited by R. M. Berne and M. N. Levy. St. Louis: The C.V. Mosby
Company, 1988, p. 745-756.
16. DWORKIN, L. D., I. ICHIKAWA, AND B. M. BRENNER. Hormonal
modulation of glomerular function. Am. J. Physiol. 244: F95-F104, 1983.
17. EVELOFF, J. L. AND D. G. WARNOCK. Activation of ion transport
systems during cell volume regulation. Am. J. Physiol. 252: F1-F10,
1987.
18. FRIEDRICH, F., M. PAULMICHL, H. A. KOLB, AND F. LANG.
Inward rectifier K channels in renal epithelioid cells (MDCK) activated
by serotonin. J. Membrane Biol. 106: 149-155, 1988.
19. GANZ, M. B., G. BOYARSKY, W. F. BORON, AND R. B. STERZEL.
Effects of angiotensin and vasopressin on intracellular pH of glomerular
mesangial cells. Am. J. Physiol. 254: F787-F794, 1988.
20. GANZ, M. B., G. BOYARSKY, R. B. STERZEL, AND W. F. BORON.
Arginine vasopressin enhances pHi regulation in the presence of HC03
by stimulating three acid-base transport systems. Nature 337: 648-651,
1989.

48

21. GANZ, M. B., S. E. KASNER, AND R. UNWIN. Acetylcholine
induces nitric oxide-dependent opening of K+ channels in glomerular
mesangial cells. J. Am. Soc. Nephrol. 1: 684, 1990. (Abstract)
22. GANZ, M. B., M. C. PERFETTO, AND W. F. BORON. Effects of
mitogens and other agents on rat mesangial cell proliferation, pH and
Ca++. Am. J. Physiol. 259: F269-F278, 1990.
23. GARAY, R. P. Inhibition of the Na+/K+ cotransport system by cyclic
AMP and intracellular Ca2+ in human red cells. Biochim. Biophys.
Acta 688: 786-792,1982.
24. GUGGINO, W. B. Potassium and cell volume. In: The Regulation of
Potassium Balance, edited by D. W. Seldin and G. Giebisch. New York:
Raven Press, 1989, p. 121-137.
25. HAEUSLER, G. Relationship between noradrenaline-induced
depolarization and contraction in vascular smooth muscle. Blood
Vessels 15: 46-54,1978.
26. HARDER, D. R. Membrane electrical activation of arterial smooth
muscle. In: Vascular Smooth Muscle: Metabolic, Ionic, and
Contractile Mechanisms, edited by M. F. Crass and C. D. Barnes. New
York: Academic Press, 1982, p. 71-97.
27. HARDER, D. R., P. D. ABEL, AND K. HERMSMEYER. Membrane
electrical mechanism of basilar artery constriction and pial artery
dilation by norepinephrine. Circ. Res. 1981.
28. HAROOTUNIAN, A. T., J. P. Y. KAO, B. K. ECKERT, AND R. Y.
TSIEN. Fluorescence ratio imaging of cytosolic free Na+ in individual
fibroblasts and lymphocytes. J. Biol. Chem. 264: 19458-19467, 1989.
29. HERMSMEYER, K. Ba2+ and K+ alteration of K+ conductance in
spontaneously active vascular muscle. Am. J. Physiol. 320: 1031-1036,
1976.
30. HOMMA, T. AND R. C. HARRIS. Time-dependent biphasic
regulation of Na+/K+/Cl- cotransport in rat glomerular mesangial cells.
J. Biol. Chem. 266:13553-13559,1991.

49

31. HOMMA, T., R. L. HOOVER, AND R. C. HARRIS. Loop diureticsensitive potassium flux pathways of rat glomerular mesangial cells.
Am. J. Physiol. 258: C862-C870, 1990.
32. ICHIKAWA, I., J. F. MIELE, AND B. M. BRENNER. Reversal of
renal cortical actions of angiotensin II by verapamil and manganese.
Kidney Int. 16:137-147,1979.
33. ITO, Y., K. KITAMURA, AND H. KURIYAMA. Effects of
acetylcholine and catecholamines on the smooth muscle cell of the
porcine coronary artery. J. Physiol. (London) 294: 595-611, 1979.
34. JEZEK, P., F. MAHDI, AND K. D. GARLID. Reconstitution of the
beef heart and rat liver mitochondrial K+/H+ (Na+/H+) antiporter. J.
Biol. Chem. 265: 10522-10526,1990.
35. KASHGARIAN, M. Mesangium and glomerular disease. Lab.
Invest. 52: 569-571,1985.
36. KASNER, S. E., W. F. BORON, AND M. B. GANZ. Measurement of
intracellular potassium in rat mesangial cells (MCs) with a newly
developed fluorescent potassium indicator. Kidney Int. 37: 563, 1990.
(Abstract)
37. KASNER, S. E. AND M. B. GANZ. Vasoactive agents influence
potassium transport in rat mesangial cells. J. Am. Soc. Nephrol. 2:
1991. (Abstract)
38. KNAUSS, T. AND H. E. ABBOUD. Effect of serotonin on
prostaglandin synthesis in rat cultured mesangial cells. Am. J.
Physiol. 251: F844-F850,1986.
39. KREISBERG, J. I., M. A. VENKATACHALAM, AND D. TROYER.
Contractile properties of cultured glomerular mesangial cells. Am. J.
Physiol. 249: F457-F463,1985.
40. KREMER, S. G., W. V. BREUER, AND K. L. SKORECKI.
Vasoconstrictor hormones depolarize renal glomerular mesangial cells
by activating chloride channels. J. Cell. Physiol 138: 97-105, 1989.
41. LANG, F., M. PAULMICHL, J. PFEILSCHIFTER, F. FRIEDRICH,
F. WOLL, S. WALDEGGER, M. RITTER, AND E. TSCHERNKO.

50

Cellular mechanisms of bradykinin-induced hyperpolarization in renal
epitheloid MDCK-cells. Biochim. Biophys. Acta 1073: 600-608, 1991.
42. LASKEY, R. F., D. J. ADAMS, A. JOHNS, G. M. RUBANYI, AND
C. VAN BREEMEN. Membrane potential and Na/K pump activity
modulate resting and bradykinin-stimulated changes in cytosolic free
calcium in cultured endothelial cells from bovine atria. J. Biol. Chem.
265: 2613-2619,1990.
43. LIGHT, D. B., E. M. SCHWEIBERT, K. H. KARLSON, AND B. A.
STANTON. Atrial natriuretic peptide inhibits a cation channel in renal
inner medullary collecting duct cells. Science 243: 383-385, 1989.
44. LOVETT, D. H., R. B. STERZEL, M. KASHGARIAN, AND J. L.
RYAN. Neutral proteinase activity produced in vitro by cells of the
glomerular mesangium. Kidney Int. 23: 342-349, 1983.
45. MACKNIGHT, A. D. C. AND A. LEAF. Cellular responses to
extracellular osmolality. In: The Kidney: Physiology and
Pathophysiology, edited by D. W. Seldin and G. Giebisch. New York:
Raven Press, 1985, p. 117-132.
46. MAHIEU, P. R., J. B. FOIDART, C. H. DUBOIS, C. A. DECHENNE,
AND J. DEHENEFFE. Tissue culture of normal rat glomeruli:
contractile activity of the cultured mesangial cells. Invest. Cell Pathol.
3:121-128,1980.
47. MALLIS, L., H. GUBER, S. A. ADLER, AND C. E. PALANT.
Intracellular chloride activity in cultured mesangial cells. Renal
Physiol. Biochem. 14: 12-18, 1991.
48. MENE, P., M. S. SIMONSON, AND M. J. DUNN. Physiology of the
mesangial cell. Physiol. Rev. 69: 1347-1424, 1989.
49. MINTA, A. AND R. Y. TSIEN. Fluorescent indicators for cytosolic
sodium. J. Biol. Chem. 264: 19449-19457, 1989.
50. NEGULESCU, P. A., A. T. HAROOTUNIAN, R. Y. TSIEN, AND T.
E. MACHEN. Fluorescence measurements of cytosolic free Na
concentration, influx, and efflux in gastric cells. Cell Regulation 1: 259268,1990.

51

51. NELSON, M. T., J. B. PATLAK, J. F. WORLEY, AND N. B.
STANDEN. Calcium channels, potassium channels, and voltage
dependence of arterial smooth muscle tone. Am. J. Physiol. 259: C3C18,1990.
52. O'DONNELL, M. E. Regulation of Na-K-Cl cotransport in
endothelial cells by atrial natriuretic factor. Am. J. Physiol. 257: C36C44,1989.
53. O'DONNELL, M. E. AND N. E. OWEN. Atrial natriuretic factor
stimulates Na/K/Cl cotransport in vascular smooth muscle cells. Pro.
Natl. Acad. Sci. USA 83: 6132-6136,1986.
54. O'DONNELL, M. E. AND N. E. OWEN. Role of cyclic GMP in atrial
natriuretic factor stimulation of Na+/K+/Cl- cotransport in vascular
smooth muscle cells. J. Biol. Chem. 261: 15461-15466, 1986.
55. OKADA, K., C. CARAMELO, P. TSAI, AND R. W. SCHRIER. Effect
of inhibition of Na+/K+-adenosine triphosphatase on vascular action of
vasopressin. J. Clin. Invest. 86: 1241-1248, 1990.
56. OKADA, K, W. ISHIKAWA, AND T. SAITO. Effect of inhibition of
Na+/K+-ATPase on the vasopressin-induced increase in intracellular
Na+ concentration in vascular smooth muscle cells. Biochem. Biophys.
Res. Comm. 177: 1247-1251, 1991.
57. OKUDA, T., I. KOJIMA, E. OGATA, AND K. KUROKAWA.
Ambient Cl- ions modify rat mesangial cell contraction by modulating
cell inositol trisphosphate Ca2+ via enhanced prostaglandin E2. J. Clin.
Invest. 84: 1866-1872,1989.
58. OKUDA, T., N. YAMASHITA, AND K. KUROKAWA. Angiotensin
II and vasopressin stimulate calcium-activated chloride conductance in
rat mesangial cells. J. Clin. Invest. 78: 1443-1448, 1986.
59. OWEN, N. E. AND K. M. RIDGE. Mechanism of angiotensin II
stimulation of Na-K-Cl cotransport of vascular smooth muscle cells.
Am. J. Physiol. 257: C629-C636, 1989.
60. PALFREY, H. C., P. W. FEIT, AND P. GREENGARD. cGMPstimulated cation cotransport in avian erythrocytes: inhibition by loop
diuretics. Am. J. Physiol. 238: C139-C148, 1980.

52

61. PALMER, L. G. The regulation of intracellular potassium. In: The
Regulation of Potassium Balance, edited by D. W. Seldin and G.
Giebisch. New York: Raven Press, 1989, p. 89-119.
62. PARIS, S. AND J. POUYSSEGUR. Growth factors activate the
bumetanide-sensitive Na/K/Cl cotransport in hamster fibroblasts. J.
Biol Chem. 261: 6177-6183, 1986.
63. PERFETTO, M. C., D. C. THROCKMORTON, M. KASHGARLAN,
AND M. B. GANZ. Transforming growth factor p (TGFJ3) transiently
modulates mesangial cell proliferation and the expression of al isoform
of the Na+/K+-ATPase pump. J. Am. Soc. Nephrol. 1: 461, 1990.
(Abstract)
64. ROTH, B. L. AND D. CHUANG. Multiple mechanisms of
serotonergic signal transduction. Life Sci. 41: 1051-1064, 1987.
65. SAVIN, V. J. AND D. A. TERREROS. Filtration in single isolated
mammalian glomeruli. Kidney Int. 20: 188-197, 1981.
66. SCHLONDORFF, D. The glomerular mesangial cell: an expanding
role for a specialized pericyte. FASEB J. 1: 272-281, 1987.
67. SCHOR, N., I. ICHIKAWA, AND B. M. BRENNER. Mechanisms of
action of various hormones and vasoactive substances on glomerular
ultrafiltration in the rat. Kidney Int. 20: 442-451, 1981.
68. SCHWARTZ, A. Positive inotropic action of digitalis and endogenous
factors: Na,K-ATPase and positive inotropy; "endogenous glycosides".
In: Current Topics in Membranes and Transport, Volume 19, edited by
J. F. Hoffman and B. Forbush. New York: Academic Press, 1983, p. 825841.
69. SIEBENS, A. W. Cellular volume control. In: The Kidney:
Physiology and Pathophysiology, edited by D. W. Seldin and G. Giebisch.
New York: Raven Press, 1985, p. 91-115.
70. SLEGAL, G., G. WEISART, R. EHEHALT, AND O. BERTSCHE.
Membrane basis of vascular regulation. In: Ionic Actions on Vascular
Smooth Muscle, edited by E. Betz. Berlin: Springer-Verlag, 1976, p. 4855.

53

71. SMITH, J. B. AND T. A. BROCK. Analysis of angiotensinstimulated sodium transport in cultured smooth muscle cells from rat
aorta. J. Cell. Physiol. 114: 284-290, 1983.
72. SMITH, J. B. AND L. SMITH. Na+/K+/Cl- cotransport in cultured
vascular smooth muscle cells: stimulation by angiotensin II and
calcium ionophores, inhibition by cyclic CMP and calmodulin
antagonists. J. Membrane Biol. 99: 51-63, 1987.
73. SMITH, J. M., A. A. SANCHEZ, AND A. J. JONES. Comparison of
rubidium-86 and potassium-42 fluxes in rat aorta. Blood Vessels 23: 297309.1986.
74. SOLTOFF, S. P. AND L. J. MANDEL. Potassium transport in the
rabbit renal proximal tubule: effects of barium, ouabain, valinomycin
and other ionophores. J. Membrane Biol. 94: 153-161, 1986.
75. SOMLYO, A. V. AND A. P. SOMLYO. Vascular smooth muscle. 1.
Normal structure, pathology, biochemistry, and biophysics. Pharmacol.
Rev. 20:197-272, 1968.
76. STERZEL, R. B. AND D. H. LOVETT. Interactions of inflammatory
and glomerular cells in the response to glomerular injury. Adv.
Nephrol. 18: 172-195,1988.
77. STRIKER, G. E., M. A. LANGE, K. MACKAY, K. BERNSTEIN,
AND L. J. STRIKER. Glomerular cells in vitro. Adv. Nephrol. 16: 169186.1987.
78. TAKEDA, K., H. MEYER-LEHNERT, J. K. KIM, AND R. W.
SCHRIER. Effect of angiotensin II on Ca2+ kinetics and contraction in
cultured rat glomerular mesangial cells. Am. J. Physiol. 254: F254F266,1988.
79. THOMAS, R. J., R. N. BUCHSBAUM, A. ZIMNIAK, AND E.
RACKER. Intracellular pH measurements in Ehrlich ascites tumor
cells utilizing spectroscopic probes generated in situ. Biochemistry 81:
2210-2218,1979.
80. WRIGHT, F. S. AND G. GIEBISCH. Regulation of potassium
excretion. In: The Kidney: Physiology and Pathophysiology, edited by D.
W. Seldin and G. Giebisch. New York: Raven Press, 1985, p. 1223-1249.

71

3 9002 01079 9063

HARVEY CUSHING / JOHN HAY WHITNEY
MEDICAL LIBRARY
MANUSCRIPT THESES

Unpublished theses submitted for the Master’s and Doctor's degrees and
deposited in the Medical Library are to be used only with due regard to the
rights of the authors.
Bibliographical references may be noted, but passages
must not be copied without permission of the authors, and without proper credit
being given in subsequent written or published work.

This thesis by
has been
used by the following persons, whose signatures attest their acceptance of the
above restrictions.

NAME AND ADDRESS

DATE

